Page last updated: 2024-11-05

1,4-phenylenebis(methylene)selenocyanate and Carcinoma, Small Cell

1,4-phenylenebis(methylene)selenocyanate has been researched along with Carcinoma, Small Cell in 1 studies

1,4-phenylenebis(methylene)selenocyanate: structure given in first source; inhibits DMBA-induced carcinogenesis by inhibiting DMBA-DNA adduct formation

Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Bayoumy, K1
Rose, DP1
Papanikolaou, N1
Leszczynska, J1
Swamy, MV1
Rao, CV1

Other Studies

1 other study available for 1,4-phenylenebis(methylene)selenocyanate and Carcinoma, Small Cell

ArticleYear
Cyclooxygenase-2 expression influences the growth of human large and small cell lung carcinoma lines in athymic mice: impact of an organoselenium compound on growth regulation.
    International journal of oncology, 2002, Volume: 20, Issue:3

    Topics: Animals; Antineoplastic Agents; Blotting, Western; Carcinoma, Large Cell; Carcinoma, Small Cell; Cel

2002